MedTrace Logo

Effect of PBM on Functional Capacity and Fatigability in Post Covid-19 Elderly

NCT05094726 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-10-26

No results posted yet for this study

Summary

Participants had randomly divided into two equal groups. Group (A) which is the study group will receive photobiomodulation session two times per week for four weeks. Group (B) will be the control group that will receive placebo photobiomodulation two times per week for four weeks.

Conditions

  • Post Covid-19 Elderly

Interventions

RADIATION

photobiomodulation

Photobiomodulation (PBM) describes the use of red or near-infrared light to stimulate, heal, regenerate, and protect tissue that has either been injured, is degenerating, or else is at risk of dying.

OTHER

placebo intervention by photobiomodulation device

placebo intervention while the photobiomodulation device is on the off mode

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Rana H El Banna, PHD · Faculty of physical therapy at Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-08
Primary Completion
2021-10-30
Completion
2021-11-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05094726 on ClinicalTrials.gov